Abstract
Most cases of acquired aplastic anemia (AA) arise from autoimmune destruction of hematopoietic stem and progenitor cells. Human leukocyte antigen (HLA)-haploidentical nonmyeloablative hematopoietic stem cell transplantation (HSCT) plus post-transplantation cyclophosphamide (PTCy) is increasingly applied to salvage AA using bone marrow as graft and anti-thymocyte globulin (ATG) in conditioning. Herein, we characterize a cohort of twelve AA patients clinically and molecularly, six who possessed other immunological disorders (including two also carrying germline SAMD9L mutations). Each patient with SAMD9L mutation also carried an AA-related rare BCORL1 variant or CTLA4 p.T17A GG genotype, respectively, and both presented short telomere lengths. Six of the ten patients analyzed harbored AA-risky HLA polymorphisms. All patients recovered upon non-HSCT (n = 4) or HSCT (n = 8) treatments. Six of the eight HSCT-treated patients were subjected to a modified PTCy-based regimen involving freshly prepared peripheral blood stem cells (PBSC) as graft and exclusion of ATG. All patients were engrafted between post-transplantation days +13 and +18 and quickly reverted to normal life, displaying a sustained complete hematologic response and an absence of graft-versus-host disease. These outcomes indicate most AA cases, including of the SAMD9L-inherited subtype, are immune-mediated and the modified PTCy-based regimen we present is efficient and safe for salvage.
Funder
Family Association for Children with Serious Illness, Taiwan
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference62 articles.
1. Giudice, V., Cardamone, C., Triggiani, M., and Selleri, C. (2021). Bone marrow failure syndromes, overlapping diseases with a common cytokine signature. Int. J. Mol. Sci., 22.
2. Aplastic anemia;Young;N. Engl. J. Med.,2018
3. Systematic review: Hepatitis-associated aplastic anaemia—A syndrome associated with abnormal immunological function;Jones;Aliment. Pharmacol. Ther.,2009
4. Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes;McReynolds;Blood,2022
5. Long-term observation of pediatric aplastic anemia;Chen;J. Formos. Med. Assoc.,1992